Synergy Pharmaceuticals LLC
(Other OTC/NBB : SGYP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.67%26.9614.1%$158.64m
AMRNAmarin Corp. Plc
22.35%20.691.7%$121.40m
BHCBausch Health Cos., Inc.
1.67%26.960.0%$120.36m
GWPHGW Pharmaceuticals Plc
-0.03%113.206.2%$83.39m
MDCOThe Medicines Co.
-2.44%54.0220.2%$79.99m
JAZZJazz Pharmaceuticals Plc
1.57%132.932.3%$70.18m
SAGESAGE Therapeutics, Inc.
2.05%147.308.6%$53.11m
PRGOPerrigo Co. Plc
-0.75%48.736.8%$46.05m
ENDPEndo International Plc
1.95%4.198.8%$46.03m
HZNPHorizon Therapeutics Plc
0.70%30.226.6%$40.82m
UTHRUnited Therapeutics Corp.
-0.96%90.0914.3%$40.78m
ICPTIntercept Pharmaceuticals, Inc.
1.55%83.2316.9%$39.61m
ICLRICON plc
0.58%147.034.1%$37.45m
CTLTCatalent, Inc.
0.34%50.022.4%$32.77m
APHAAphria, Inc.
-0.97%4.920.0%$27.80m

Company Profile

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.